Williams Jones & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $889K | Buy |
16,321
+3,049
| +23% | +$166K | 0.02% | 214 |
|
|
2019
Q1 | $716K | Sell |
13,272
-47,605
| -78% | -$2.57M | 0.02% | 231 |
|
|
2018
Q4 | $3.99M | Buy |
60,877
+2,067
| +4% | +$135K | 0.11% | 121 |
|
|
2018
Q3 | $4.63M | Hold |
58,810
| – | – | 0.09% | 133 |
|
|
2018
Q2 | $3.78M | Sell |
58,810
-2,840
| -5% | -$183K | 0.08% | 141 |
|
|
2018
Q1 | $3.84M | Sell |
61,650
-187
| -0.3% | -$11.6K | 0.09% | 134 |
|
|
2017
Q4 | $4.48M | Buy |
61,837
+437
| +0.7% | +$31.7K | 0.1% | 129 |
|
|
2017
Q3 | $4.99M | Buy |
61,400
+1,200
| +2% | +$97.6K | 0.12% | 119 |
|
|
2017
Q2 | $4.84M | Sell |
60,200
-14,180
| -19% | -$1.14M | 0.12% | 125 |
|
|
2017
Q1 | $5.84M | Sell |
74,380
-5,100
| -6% | -$400K | 0.15% | 119 |
|
|
2016
Q4 | $6.27M | Sell |
79,480
-21,968
| -22% | -$1.73M | 0.18% | 112 |
|
|
2016
Q3 | $9.03M | Sell |
101,448
-7,237
| -7% | -$644K | 0.26% | 84 |
|
|
2016
Q2 | $10.4M | Sell |
108,685
-262,311
| -71% | -$25.1M | 0.32% | 77 |
|
|
2016
Q1 | $38.5M | Sell |
370,996
-4,145
| -1% | -$430K | 1.79% | 13 |
|
|
2015
Q4 | $36.7M | Sell |
375,141
-11,911
| -3% | -$1.16M | 1.68% | 17 |
|
|
2015
Q3 | $37.3M | Buy |
387,052
+24,178
| +7% | +$2.33M | 1.68% | 16 |
|
|
2015
Q2 | $38.1M | Buy |
362,874
+152,945
| +73% | +$16M | 1.46% | 16 |
|
|
2015
Q1 | $21.7M | Buy |
209,929
+137,742
| +191% | +$14.2M | 0.87% | 28 |
|
|
2014
Q4 | $6.95M | Buy |
72,187
+53,896
| +295% | +$5.19M | 0.29% | 89 |
|
|
2014
Q3 | $1.46M | Sell |
18,291
-11
| -0.1% | -$876 | 0.07% | 149 |
|
|
2014
Q2 | $1.38M | Sell |
18,302
-13,202
| -42% | -$995K | 0.06% | 147 |
|
|
2014
Q1 | $2.36M | Buy |
31,504
+18,119
| +135% | +$1.36M | 0.05% | 174 |
|
|
2013
Q4 | $958K | Buy |
13,385
+2,200
| +20% | +$157K | 0.05% | 154 |
|
|
2013
Q3 | $635K | Buy |
11,185
+485
| +5% | +$27.5K | 0.03% | 177 |
|
|
2013
Q2 | $612K | Buy |
+10,700
| New | +$612K | 0.03% | 201 |
|